Welcome to our dedicated page for DELPHX CAP MKTS news (Ticker: $DPXCF), a resource for investors and traders seeking the latest updates and insights on DELPHX CAP MKTS stock.
Our selection of high-quality news articles is accompanied by an expert summary from Rhea-AI, detailing the impact and sentiment surrounding the news at the time of release, providing a deeper understanding of how each news could potentially affect DELPHX CAP MKTS's stock performance. The page also features a concise end-of-day stock performance summary, highlighting the actual market reaction to each news event. The list of tags makes it easy to classify and navigate through different types of news, whether you're interested in earnings reports, stock offerings, stock splits, clinical trials, fda approvals, dividends or buybacks.
Designed with both novice traders and seasoned investors in mind, our page aims to simplify the complex world of stock market news. By combining real-time updates, Rhea-AI's analytical insights, and historical stock performance data, we provide a holistic view of DELPHX CAP MKTS's position in the market.
Rhea-AI Summary
DelphX Capital Markets Inc. announced the closing of a non-brokered unit financing, raising gross proceeds of C$400,000 through the issuance of 5,000,000 units at C$0.08 per unit. Insiders subscribed for 2,812,500 units, constituting a related party transaction under MI 61-101 and TSXV Policy 5.9. The offering includes common shares and warrants, with finder's fees paid to AlphaNorth Asset Management. The TSX Venture Exchange has conditionally accepted the offering, with securities subject to a hold period of four months plus one day. The net proceeds will be used for launching the Company's Credit Rating Security (CRS) product and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
DelphX Capital Markets Inc. (DPXCF) partners with Castle Placement, to enhance market exposure for its DelphX Credit Rating Security product, benefiting from Castle's vast investor network and expertise in facilitating transactions. The agreement includes revenue sharing on all CRS transactions sourced through Castle, further supporting DelphX in future capital raising.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
News
Rhea-AI Summary
DelphX Capital Markets Inc. announces industry veteran Barry Finklestein joining as a consultant to aid in the commercialization and development of proprietary credit products. Finklestein brings over three decades of experience in fixed income and structured products, with executive positions at Enigma Securities, Algorand, UBS, and Merrill Lynch. His role will be crucial in commercializing the recently introduced Credit Rating Security (CRS) to provide portfolio managers and traders with the ability to position against rating downgrades on individual bonds.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
DelphX Capital Markets Inc. has closed an over-subscribed non-brokered private placement, raising gross proceeds of C$468,500. The Offering consisted of 3,904,166 units, with insiders participating for 1,208,333 units. DelphX will pay cash finder's fees of $8,400 and issue 70,000 finders' warrants to AlphaNorth Asset Management. The net proceeds will be used for the launch of the Company's novel Credit Rating Security (CRS) product and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
DelphX Capital Markets Inc. announces the appointment of Jonathan Deeter as Director of Credit Product Sales to drive the commercialization of the DelphX Credit Rating Security (CRS) product. The expansion of the sales team aligns with the company's strategic plan to promote the CRS product. Jonathan Deeter brings a strong background in fintech business development and operational experience within the structured products space. The DelphX CRS product aims to address a previously unmet need in the structured products market by providing actionable opportunities during potential rating changes on existing bonds.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) announces Jeffrey Nabi as Managing Director, Credit Product Sales, to lead the commercialization phase of the DelphX Credit Rating Security (CRS) product. The company also approved the grant of 900,000 stock options to eligible participants under its stock option plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) is expanding its business operations by adding a new vertical through the creation of an in-house sales team, targeting institutional customers for its novel Credit Rating Security (CRS) product. The company aims to improve margins and revenue expectations by retaining all revenue from each transaction and gaining better control over the commercialization process.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
10.68%
Tags
-
Rhea-AI Summary
DelphX Capital Markets Inc. (TSXV: DELX) (OTCQB: DPXCF) announces the approval of 2,325,000 stock options for eligible participants under its stock option plan.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
-
Rhea-AI Summary
DelphX Capital Markets Inc. has closed an over-subscribed non-brokered private placement, raising gross proceeds of C$418,040. The offering consisted of 3,483,668 units at a subscription price of C$0.12 per unit. Each unit includes one common share and one common share purchase warrant. Insiders participated in the offering, and the company plans to use the net proceeds for the launch of its novel Credit Rating Security (CRS) product and general corporate purposes.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
Rhea-AI Summary
DelphX Capital Markets provides operational update on the launch of their novel Credit Rating Security (CRS) product. The company has completed all document approvals and pre-launch requirements and is currently working with two Qualified Institutional Buyers (QIBs) to negotiate the terms and conditions of the first commercial transaction. DelphX plans to complete this transaction in early Q4 2023 and is in late-stage discussions with hedge funds and dealers for wider adoption of the CRS product.
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
DELPHX CAP MKTS INC
OTC:DPXCF
DPXCF Rankings
DPXCF Stock Data
14.03M
72.59M
36.55%
14.45%
Investment Banking and Securities Dealing
Finance and Insurance
United States of America
Toronto